Companies / Spica Therapeutics
Spica Therapeutics
Company
Spica Therapeutics identifies and selectively targets disease-driving macrophage subsets to transform outcomes in oncology, fibroinflammatory and other chronic diseases.
Spica Therapeutics has 2 investors on file, among them PMV and Qbic. Its site was last checked 13 Nov 2026: site answers.
Investors
2 investors on fileMore from PMV
89 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (21%), AI & Machine Learning (19%), Industrial & Manufacturing (12%).
More from Qbic
43 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (42%), AI & Machine Learning (20%), Industrial & Manufacturing (17%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Spica Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when PMV adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/spicatx.com/investors
# also
GET /v1/companies/spicatx.com
GET /v1/companies/spicatx.com/news